Adicet Bio, Inc. Share Price
ACETAdicet Bio, Inc. Stock Performance
Open $8.07 | Prev. Close $8.09 | Circuit Range N/A |
Day Range $7.97 - $8.09 | Year Range $0.45 - $8.80 | Volume 4,176 |
Average Traded $8.03 |
Adicet Bio, Inc. Share Price Chart
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $8.07 | $8.00 | +0.00% |
06-Jan-26 | $8.07 | $8.00 | -1.72% |
05-Jan-26 | $8.64 | $8.14 | -7.50% |
02-Jan-26 | $8.62 | $8.80 | +4.64% |
31-Dec-25 | $7.93 | $8.41 | +6.19% |
30-Dec-25 | $8.01 | $7.92 | +1,459.06% |
29-Dec-25 | $0.50 | $0.51 | -1.55% |